Back to UBS Group AG UBS Group AG

STIMSTIM
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in NEURONETICS INC

UBS Group AG holds 2.3M shares of STIM (NEURONETICS INC), worth $3M as of 2026-Q2. The position was decreased (-20.6% shares). STIM represents 0.0% of UBS Group AG's portfolio.

Current Value

$3M

Current Shares

2.3M

Total Value Change

+$3M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.3M
-20.6%
$3M0.0%$1.30
0
2026-Q1
Increased
2.9M
+10.1%
$4.2M0.0%$1.27
29
2025-Q4
Increased
2.6M
+20.4%
$3.6M0.0%$1.41
32
2025-Q3
Increased
2.2M
+580.7%
$5.9M0.0%$2.66
44
2025-Q2
Increased
318,030
+183.7%
$1.1M0.0%$3.53
41
2025-Q1
Decreased
112,114
-72.2%
$412,5800.0%$3.77
0
2024-Q4
Increased
403,624
+6100.1%
$649,8350.0%$1.48
39
2024-Q3
Decreased
6,510
-90.2%
$4,9470.0%$0.75
0

Other major holders of STIM: BNP PARIBAS FINANCIAL MARKETS, Capital Research Global Investors, Polar Capital Holdings Plc, ROYCE & ASSOCIATES LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used